Pharmaceutical company
Appears in 1 story
Developer and U.S. commercializer of WELTRUZA
Teva's WELTRUZA is the first once-monthly subcutaneous injection of olanzapine for schizophrenia. Patients skip loading doses, oral supplementation, and the post-injection clinic stay that defined the previous injectable form of this drug.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
